• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down3.39% Nasdaq Down4.12%

    INSYS Therapeutics, Inc. (INSY)

    -NasdaqGM
    12.62 Down 0.45(3.44%) Jun 24, 4:00PM EDT
    |After Hours : 12.62 0.00 (0.00%) Jun 24, 5:23PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue 330,797   222,125   99,289  
    Cost of Revenue28,854  22,578  12,665  
    Gross Profit 301,943   199,547   86,624  
    Operating Expenses
    Research Development55,281  33,136  8,499  
    Selling General and Administrative144,717  102,388  45,566  
    Non Recurring9,515   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 92,430   64,023   32,559  
    Income from Continuing Operations
    Total Other Income/Expenses Net538  153  (32)
    Earnings Before Interest And Taxes92,968  64,176  32,527  
    Interest Expense -   -  950  
    Income Before Tax92,968  64,176  31,577  
    Income Tax Expense34,492  26,199  (8,800)
    Minority Interest -   -   -  
    Net Income From Continuing Ops58,476  37,977  40,377  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 58,476   37,977   40,377  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 58,476   37,977   40,377  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.